Proportion of children who received DTP3 or Penta 3 ‐ HBRf only · children aged 1 year
Home‐based record combined with other interventions may leads to higher proportion of children who received DTP3 or Penta 3 ‐ HBRf only compared with routine care (low certainty).
1 finding from 1 review
Proportion of children who received DTP3 or Penta 3 ‐ HBR + health educationg · children aged 1 year
Home‐based record combined with other interventions may leads to higher proportion of children who received DTP3 or Penta 3 ‐ HBR + health… compared with routine care (low certainty).
1 finding from 1 review
Proportion of children who received DTP3 or Penta 3 ‐ HBR + stickerh · children aged 1 year
Home‐based record combined with other interventions may leads to higher proportion of children who received DTP3 or Penta 3 ‐ HBR + stickerh compared with routine care (low certainty).
1 finding from 1 review
Proportion of children who received all recommended vaccines by 2 years of age · children aged 1 year
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Proportion of children who received the vaccine under study · children aged 1 year
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Proportion of children under 5 years of age fully immunised with all scheduled vaccines · children aged 1 year
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Occurrence of vaccine‐preventable diseases · children aged 1 year
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cost of the intervention · children aged 1 year
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · children aged 1 year
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
ACT use (percentage of children under 5 years receiving ACT on the same day or following day of fever onset) · Patients seeking treatment for suspected uncomplicated malaria
1 finding from 1 review
ACT availability (percentage of outlets stocking ACTs for children under 5 years) · Patients seeking treatment for suspected uncomplicated malaria
1 finding from 1 review
no estimate extracted
1 study · 2 participants
High
ACT availability (percentage of outlets stocking at least one ACT for patients of any age) · Patients seeking treatment for suspected uncomplicated malaria
1 finding from 1 review
no estimate extracted
1 study · 1 participants
Very low
ACT price (change in ACT prices for children under 5 years)c · Patients seeking treatment for suspected uncomplicated malaria
1 finding from 1 review
no estimate extracted
1 study · 1 participants
High
ACT market share (volume of ACTs purchased as a proportion of all antimalarials purchased; all age groups) · Patients seeking treatment for suspected uncomplicated malaria
1 finding from 1 review
no estimate extracted
1 study · 2 participants
High
Use of older antimalarials (amodiaquine, sulphadoxine‐pyrimethamine; children under 5 years) · Patients seeking treatment for suspected uncomplicated malaria
1 finding from 1 review
no estimate extracted
1 study · 1 participants
High
Adverse effects (such as the number of people receiving ACTs who do not have malaria) · Patients seeking treatment for suspected uncomplicated malaria
1 finding from 1 review